Figure Gallery

Expression Pattern Search Results for RFP

(278 figures with expression from 173 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Pipalia et al., 2016	Fig. 6	csf1ra^{tm236b/tm236b}; pax7b^{nkgsaizGFFD164AGt}; nkuasrfp1aTg; t32239Tg	perforation: epaxial myotome region	Day 4 to Day 5	muscle precursor cell regenerating tissue muscle cell
	Fig. 7	csf1ra^{tm236b/tm236b}; pax7b^{nkgsaizGFFD164AGt}; nkuasrfp1aTg; t32239Tg	perforation: epaxial myotome region	Protruding-mouth to Day 5	muscle precursor cell regenerating tissue muscle precursor cell
Rochon et al., 2016	Fig. 2	pt505Tg pt505Tg + MO3-acvrl1	control	Prim-5 to Prim-25	aortic arch 1 caudal division of the internal carotid artery cranial vasculature endothelial cell membrane internal carotid artery
	Fig. 5	pt505Tg; y7Tg pt505Tg; y7Tg + MO3-acvrl1	control	Prim-5	aortic arch 1 endothelial cell endothelial cell membrane
Seytanoglu et al., 2016	Fig. 5	vu234Tg gle1^{hi4161aTg/hi4161aTg}; vu234Tg	standard conditions	Long-pec	posterior lateral line myelinating Schwann cell
Valdivia et al., 2016	Fig. 2	cu2Tg; nns1Tg gdf6a^u900/u900; cu2Tg; nns1Tg	standard conditions	Protruding-mouth	retinal ganglion cell
Yin et al., 2016	Fig. 4	bw14Tg bw13Tg	standard conditions	Long-pec to Protruding-mouth	pronephric tubule
	Fig. 6	bw16Tg; cz1701Tg	chemical treatment: afimoxifene	Day 4	pronephric tubule
Boer et al., 2015	Fig. 8	vu234Tg vu234Tg + MO2-cxcr4a fscn1a^{zd1012/zd1012}; vu234Tg fscn1a^{zd1012/zd1012}; vu234Tg + MO2-cxcr4a	standard conditions standard conditions	Prim-5	neural crest filopodium membrane
	Fig. 3	vu234Tg fscn1a^{zd1012/zd1012}; vu234Tg	standard conditions	Prim-5	ectomesenchyme filopodium membrane neural crest filopodium membrane neural crest membrane trunk neural crest filopodium membrane
	Fig. 6	vu234Tg fscn1a^{zd1012/zd1012}; vu234Tg	control chemical treatment: pharmaceutical	Prim-5	neural crest filopodium membrane neural crest membrane
Deng et al., 2015	Fig. 11	zf666Tg	control	Day 6	nucleate erythrocyte
Dubrulle et al., 2015	Fig. 2	a147Tg; a148Tg	standard conditions	50%-epiboly	whole organism nucleus
Fadeev et al., 2015	Fig. 4	t32238Tg; tdl358Et tjp1a^{tnh009b/tnh009b}; t32238Tg; tdl358Et	standard conditions	Days 14-20 to Days 21-29	pigment cell membrane
Hao et al., 2015	Fig. 2	os44Tg os45Tg os46Tg	standard conditions	Prim-5	motor neuron axon motor neuron cell body
	Fig. 3	os44Tg	standard conditions	Long-pec to Days 7-13	motor neuron axon motor neuron cell body
	Fig. 6	vu234Tg smn1^fh229/fh229; vu234Tg smn1^fh229/fh229; os44Tg; vu234Tg	standard conditions	Day 6	myelinating Schwann cell
	Fig. 9	smn1^fh229/fh229; os44Tg; w61Tg	standard conditions	Long-pec to Day 4	motor neuron axon motor neuron cell body
	Fig. 10	smn1^fh229/fh229; os44Tg; w61Tg	standard conditions	Long-pec to Day 4	motor neuron cell body
	Fig. 11	smn1^fh229/fh229; os44Tg; w61Tg	standard conditions	Long-pec	motor neuron axon motor neuron cell body
Jing et al., 2015	Fig. 6	hkz08tTg; la4Tg hkz08tTg; la4Tg + MO1-adora2b	standard conditions control chemical treatment: BAY 60-6583	Prim-15	dorsal aorta ventral wall of dorsal aorta
	Fig. 7	hkz08tTg; la4Tg hkz08tTg; la4Tg + MO1-cxcl8a	standard conditions control	Prim-15	ventral wall of dorsal aorta ventral wall of dorsal aorta angioblastic mesenchymal cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 8	hkz08tTg; la4Tg	control chemical treatment: N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide dihydrochloride	Prim-15	dorsal aorta
	Fig. 2	la4Tg; zf169Tg la4Tg; zf169Tg + MO1-adora2b	standard conditions control chemical treatment: BAY 60-6583	Prim-25	endothelial cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 1	la4Tg; zf169Tg	control chemical treatment: N-ethyl-5'-carboxamidoadenosine chemical treatment: CGS 15943	Prim-25	endothelial cell ventral wall of dorsal aorta hematopoietic multipotent progenitor cell